Novel ADC Could Expand Treatment Options in Ovarian Cancer | HappeningNow.news

Health · 5 views

Novel ADC Could Expand Treatment Options in Ovarian Cancer

(MedPage Today) -- Updated results from the FONTANA trial presented at the annual European Society for Medical Oncology congress showed promising activity with the investigational antibody-drug conjugate (ADC) torvutatug samrotecan…

Source Summary Published 1h 56m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 5 Community interest
Brief read Under 1 min brief 31 words

Summary

(MedPage Today) -- Updated results from the FONTANA trial presented at the annual European Society for Medical Oncology congress showed promising activity with the investigational antibody-drug conjugate (ADC) torvutatug samrotecan (torvu-sam

Read original at MedPage Today

Coverage Context

Part of ADC coverage 25 tracked stories

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page